Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2004 | 06-2003 | 06-2002 | 06-2001 | 06-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 853 | -161 | 1,871 | 396 | 533 |
| Depreciation Amortization | 279 | 281 | 321 | 954 | 940 |
| Income taxes - deferred | 415 | -194 | 1,053 | 616 | 426 |
| Accounts receivable | -641 | 1,814 | 1,098 | -2,519 | 120 |
| Accounts payable and accrued liabilities | -19 | -15 | -489 | 564 | -129 |
| Other Working Capital | -457 | 593 | 582 | -1,381 | -1,063 |
| Other Operating Activity | 660 | -1,799 | -609 | 1,955 | 9 |
| Operating Cash Flow | $1,090 | $519 | $3,827 | $585 | $836 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -122 | -71 | -82 | -83 | -144 |
| Investing Cash Flow | $-122 | $-71 | $-82 | $-83 | $-144 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -3,600 | -1,700 | -1,700 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 35 |
| Financing Cash Flow | $N/A | $N/A | $-3,600 | $-1,700 | $-1,665 |
| Beginning Cash Position | 1,922 | 1,474 | 1,329 | 2,527 | 3,500 |
| End Cash Position | 2,890 | 1,922 | 1,474 | 1,329 | 2,527 |
| Net Cash Flow | $968 | $448 | $145 | $-1,198 | $-973 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,090 | 519 | 3,827 | 585 | 836 |
| Capital Expenditure | -122 | -71 | -82 | -83 | -144 |
| Free Cash Flow | 968 | 448 | 3,745 | 502 | 692 |